Adverse events after mechanical thrombectomy in the 2 groups
| Overall Sample | PSM Sample | |||||||
|---|---|---|---|---|---|---|---|---|
| AT Group, n (%) (n = 40) | SRT Group, n (%) (n = 69) | OR (95% CI) | P | AT Group, n (%) (n = 30) | SRT Group, n (%) (n = 30) | OR (95% CI) | P | |
| Overall adverse events | 21 (52.5) | 50 (72.5) | 0.42 (0.19–0.95) | .035 | 14 (46.7) | 20 (66.7) | 0.44 (0.15–1.24) | .118 |
| Any ICH | 12 (30.0) | 28 (40.6) | 0.63 (0.27–1.44) | .269 | 6 (20.0) | 14 (46.7) | 0.29 (0.09–0.90) | .028 |
| Symptomatic ICH | 4 (10.0) | 14 (20.3) | 0.44 (0.13–1.43) | .260 | 3 (10.0) | 8 (26.7) | 0.31 (0.07–1.29) | .182 |
| Downstream territory embolism | 17 (42.5) | 31 (44.9) | 0.91 (0.41–1.99) | .806 | 11 (36.7) | 11 (36.7) | 1.00 (0.35–2.86) | .999 |
| Malignant cerebral edema | 4 (10.0) | 19 (27.5) | 0.29 (0.09–0.93) | .050 | 4 (13.3) | 5 (16.7) | 0.77 (0.19–3.20) | .999 |
| All-cause mortality at 90 days | 6 (15.0) | 12 (17.4) | 0.84 (0.29–2.44) | .746 | 6 (20.0) | 6 (20.0) | 1.00 (0.28–3.54) | .999 |